Skip to main content
Mind Medicine (MindMed) Inc. logo

Mind Medicine (MindMed) Inc. — Investor Relations & Filings

Ticker · MNMD ISIN · CA60255C8850 LEI · 549300QY8KN1O6RPFJ13 US Manufacturing
Filings indexed 439 across all filing types
Latest filing 2026-05-19 Report Publication Anno…
Country CA Canada
Listing US MNMD

About Mind Medicine (MindMed) Inc.

https://ir.mindmed.co/

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders. The company's research and development pipeline focuses on innovative treatments derived from psychedelics and other novel compounds. These candidates, which include substances with and without acute perceptual effects, are designed to target key neurotransmitter pathways. MindMed's mission is to deliver therapies that address unmet patient needs in psychiatry, with clinical programs investigating treatments for conditions such as Major Depressive Disorder.

Recent filings

Filing Released Lang Actions
8-K
Report Publication Announcement Classification · 93% confidence The document is a short SEC Form 8-K (2896 characters) under Items 8.01 and 9.01 that simply announces that an updated corporate presentation has been posted to the company’s website and filed as Exhibit 99.1. It contains no actual presentation content or substantive financial data—only a notice that the presentation is attached by reference. Under the “Menu vs Meal” rule, this is an announcement of a report’s publication, not the report itself, matching the definition of a Report Publication Announcement (RPA).
2026-05-19 English
8-K - Definium Therapeutics, Inc. (0001813814) (Filer)
Regulatory Filings Classification · 90% confidence The document is a U.S. SEC Form 8-K “Current Report” announcing a press release regarding an operational event (first patient dosed) and filing exhibits. It is an Exchange Act event-driven regulatory report rather than an earnings release, financial statement, or management presentation itself. Under the classification scheme, standalone SEC Form 8-K filings fall into the general “Regulatory Filings” category (RNS).
2026-05-12 English
4 - Definium Therapeutics, Inc. (0001813814) (Issuer)
Director's Dealing
2026-03-26 English
4 - Definium Therapeutics, Inc. (0001813814) (Issuer)
Director's Dealing
2026-03-26 English
4 - Definium Therapeutics, Inc. (0001813814) (Issuer)
Director's Dealing
2026-03-26 English
144 - Definium Therapeutics, Inc. (0001813814) (Subject)
Regulatory Filings
2026-03-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.